Published in Vaccine Weekly, November 16th, 2005
Study 1: Immunoprophylaxis with DNA vaccination inhibits Th2-mediated responses and airway inflammation in mice sensitized with the major timothy grass pollen allergen.
"DNA vaccination is discussed as having the potential of improving therapy of type I allergies. A mouse model was used to investigate the effect of DNA vaccination against sensitization with the clinically relevant Phl p 5b major allergen from timothy grass pollen in an immunoprophylactic experimental setup," researchers in Germany report.
"Pre-treating the mice with Phl p...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-11-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.